Forbright (FRBT) analyst forecast and price target
Analyst forecast
Consensus of 6 analyst ratings
Based on 5 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Wells Fargo | Maintained | Overweight | $22.00 from $21.00 | Aug 10, 2026 |
| JP Morgan | Maintained | Neutral | $23.00 from $21.00 | Jul 31, 2026 |
| Wells Fargo | Initiated Coverage | Overweight | $21.00 | Jul 6, 2026 |
| Goldman Sachs | Initiated Coverage | Buy | $23.50 | Jul 6, 2026 |
| JP Morgan | Initiated Coverage | Neutral | $21.00 | Jul 6, 2026 |
| Piper Sandler | Initiated Coverage | Neutral | $21.50 | Jul 6, 2026 |
| TD Cowen | Initiated Coverage | Buy | — | Jul 6, 2026 |
| Barclays | Initiated Coverage | Overweight | $23.00 | Jul 6, 2026 |
Frequently asked questions
What is the price target for FRBT stock?
The average 12-month analyst price target for Forbright (FRBT) is $22.60, with a high estimate of $23.50 and a low of $21.50, across 5 analysts.
Is FRBT a buy, sell, or hold?
Analysts covering Forbright currently average a Buy rating: 4 buy, 2 hold and 0 sell, from 6 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for FRBT?
The average price target of $22.60 implies 23.43% upside from the last price of $18.31.
What is the latest analyst rating on FRBT?
On Aug 10, 2026, Wells Fargo maintained Forbright at Overweight with a price target of $22.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.